3649 results for «684»
3649 results
CABG vs. PCI - Multivessel disease
15 Dec 2022 – From GulfPCR-GIM 2022
Watch this GulfPCR-GIM 2022 session to find out more about the guidelines in revascularisation for multivessel disease, simplification of multivessel disease PCI using physiological guidance, and much more!
All you need to know on physiology: a 2023 update
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, listen to William Wijns discuss the following physiology topics: long-term data on PCI deferral, update on new "negative" studies, low adoption in daily practice, and computational image-based physiology.
Challenging and complication cases
15 Dec 2022 – From GulfPCR-GIM 2022
Watch this GulfPCR-GIM 2022 session to learn how to deal with post-infarction ventricular rupture, an unusual post-CABG complication, a left main complication with the LACOSTE technique, the entrapment of a knotted catheter in the radial artery during primary PCI, and much more!
GulfPCR-GIM 2022 - Closing Ceremony
15 Dec 2022 – From GulfPCR-GIM 2022
Listen to the Course Directors thank all the participants and take stock of this 2022 edition, insisting in particular on the role of imaging, which must not however make us forget the basics of interventional cardiology, before attending the prize-giving ceremony for the best clinical cases...
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
